Colorectal cancer
Conditions
Interventions
therapy group:Jianpi+ Western medicine chemotherapy
Control group: Placebo + Western medicine chemotherapy
Sponsors
Shanghai Municipal Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) TNM stage I-III colorectal cancer postoperative patients (American Joint Committee on Cancer (AJCC) / International Union Against Cancer (UICC) colorectal cancer TNM staging system (7 version); 2) Syndrome of spleen and kidney yang type (main symptoms: abdominal pain hi warm press, the next benefit clear valley or more diarrhea, or see the stool blood, pale, less gas weakness, aversion to cold, backache knee soft , Pale tongue, with teeth marks, thin white fur, pulse Shen thin, etc.); 3) Karnofsky score =60; 4) the expected survival time = 3 months; 5) Aged at least 18 years; 6) no severe heart, liver, kidney, hematopoietic system disorders and other factors that affect drug evaluation.
Exclusion criteria
Exclusion criteria: 1) those who do not meet the inclusion criteria. 2) have significant heart, liver, kidney or hematopoietic dysfunction, or mental illness, pregnant or lactating women. 3) is participating in other drug trials. 4) not in accordance with the provisions of medication or information is incomplete. 5) the researchers believe that should not participate in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Chinese medicine syndrome score;Quality of life;Safety-related physical and chemical indicators;Disease-free survival, DFS;overall survival, OS; | — |
Secondary
| Measure | Time frame |
|---|---|
| Imaging index; | — |
Countries
China
Contacts
Public ContactJianlin Ren
Shanghai Municipal Hospital of Traditional Chinese Medicine
Outcome results
None listed